Skip to content
Tirzepatide Report
Provider review

Gide Health Tirzepatide Review: Prices, Care and Refund Terms

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Gide Health names compounded tirzepatide in its weight-loss offering and has a dedicated tirzepatide intake route. Its public pages also leave a difficult buying question: which price, supply and refund promise actually apply to that prescription?124

The service describes online clinical review and delivery, with care supplied through an independent network. It could be relevant for someone comparing personalized compound programs, but the headline amounts do not establish a clear monthly tirzepatide quote. This review examines public information checked in October 2026; it does not reflect a purchase or treatment experience.

Before you choose

What is publishedWhat to confirm
Named compounded tirzepatide intakeExact formulation, prescribed dose and supply
From $196/month on a six-month plan; $299 product starting priceWhich applies to your tirzepatide plan and total due
Beluga Health named in termsAssigned clinician and ongoing clinical access
Mississippi, New Mexico and Louisiana excluded in termsYour state and current prescription availability
Money-back marketing; final-sale conditionsWritten guarantee eligibility and refund cutoff
Public information checked October 2026. Final terms depend on the selected plan and clinical review.

Is tirzepatide actually offered?

The weight-loss page expressly includes compounded semaglutide or tirzepatide. The enrollment link from its Advanced GLP-1 product page leads to a page titled “Tirzepatide - Personalized (Billing Plans).” This supports the existence of a named tirzepatide pathway rather than a conclusion based only on GLP-1/GIP marketing.14

There is still an important distinction between a published pathway and access for you. We did not submit health information or complete checkout. The medicine, dose, cost and clinical suitability therefore remain subject to an actual consultation. A visible intake route is not a prescription approval.

Why the advertised prices need clarification

Gide's weight-loss page displays an Advanced GLP-1 amount of as low as $196 per month on a six-month plan. The dedicated Advanced GLP-1 product page instead gives a $299 monthly starting price. That same product page contains a semaglutide heading, even though its enrollment link names tirzepatide.124

These observations do not establish that either amount is wrong. They establish that the public presentation does not consistently connect one price to a specified tirzepatide formulation, dose and billing arrangement. We would not use $196 as a verified flexible monthly tirzepatide price, or $299 as a confirmed all-dose quote.

Ask for one written offer that identifies the medication, prescribed milligrams, quantity, days supplied, total charged today and renewal amount. If a six-month price is offered, check whether the entire period is payable upfront, whether deliveries arrive monthly and what happens if treatment changes. A monthly equivalent can be useful for comparing plans, but only once the payment commitment is clear. A canceled clinical treatment plan and a canceled financial commitment may follow different rules.

Who reviews the prescription?

The terms say Gide facilitates telehealth access and names Beluga Health as a network partner for licensed-provider consultations and prescriptions. They distinguish Gide's platform role from medical care. The product page describes an online assessment, clinician review and shipment after approval; the weight-loss page describes continuing support.23

Before committing, find out who your treating clinician will be, how to reach that clinician between reviews and whether the price includes future visits. “Support” can mean administrative help, prescription follow-up or a separate clinical appointment. The useful comparison is the service you can actually obtain when you have symptoms, need a dose change or need to stop treatment.

We did not independently verify a clinician assignment, a response-time guarantee or the details of a patient's follow-up schedule. A named network gives more information than a generic physician-review badge, but it does not answer those patient-specific questions.

State access and eligibility

Gide's terms require users to be at least 18 and list Mississippi, New Mexico and Louisiana as states it does not serve. These are published service limits, not a clinical eligibility determination or proof that every other state supports every formulation.3

Confirm your state and your physical location during the visit before paying. Also ask whether a live visit or laboratory testing is required for your circumstances, whether either adds a charge, and how changes in location affect refills. Neither a completed eligibility quiz nor a general weight-loss goal guarantees a prescription.

The pharmacy is still a deciding gap

The reviewed terms refer to affiliated pharmacies and say pharmacy services have their own conditions. The inspected pages did not establish the legal identity of the pharmacy that would dispense a particular tirzepatide order.3

Obtain the actual pharmacy's name, address and contact information, then check its authorization to dispense in your state. Ask for the full formulation, concentration, written dosing instructions, storage requirements and beyond-use date. A general statement that medicine comes from licensed facilities cannot substitute for the dispenser shown on your prescription label.

FDA states that compounded GLP-1 drugs are not FDA-approved and do not undergo its premarket review for safety, effectiveness and quality. FDA recommends compounded drugs only when a patient's medical needs cannot be met by an approved drug.5 A compounded offer should be compared with the approved treatment that your clinician considers appropriate, including insurance coverage and follow-up requirements.

A money-back headline and final-sale terms

The weight-loss page advertises a weight-loss money-back promise. The terms say purchases are final and describe a refund cutoff once services have begun or a prescription has been sent to the pharmacy. The terms also disclaim guaranteed results.13

We did not find a complete set of conditions reconciling that marketing promise with the final-sale language. Do not assume the headline creates an unconditional right to recover the cost of a consultation or dispensed prescription. Request the policy applicable to your chosen plan, including qualifying duration, documentation, exclusions and the exact amount refundable.

Also separate three events: canceling before clinical work begins, stopping future renewals and seeking a refund after treatment has started. Ask for the deadline and process for each, and retain the written response with your order confirmation. If a provider decides treatment is unsuitable, clarify what happens to any payment already collected. The inspected language does not justify inventing a blanket medical-denial refund guarantee.

How we would compare Gide

Gide supplies enough information to identify a named compounded tirzepatide pathway and a care-network arrangement. Its most material limits are the inconsistent price presentation, unspecified patient-assigned pharmacy and unresolved guarantee conditions. The evidence does not support ranking it on clinical results or describing it as the cheapest option.

A useful next step is a complete written quote and contract, with your formulation and state identified. If those answers are unclear, choose a comparison whose cost and cancellation rules you can understand before committing. Our provider reviews, care-options guide and Zepbound cost guide can help frame that comparison.

Keep marketing claims separate from treatment instructions

Gide’s Advanced product page advertises weekly or bi-weekly dosing and 20–30% weight loss. Those statements are marketing claims, not independently verified outcomes for this program. The approved Zepbound schedule is once weekly, with dose escalation directed by a prescriber. A compounded product is not the branded treatment studied in the registration trials; do not adopt a different interval from a sales page.26

Frequently asked questions

Does Gide Health offer tirzepatide?

Its weight-loss page names compounded tirzepatide and its product enrollment route leads to a named tirzepatide intake. Individual availability and eligibility require clinical review.

Is Gide tirzepatide $196 or $299 per month?

The weight-loss page displays $196/month on a six-month Advanced GLP-1 plan; the dedicated Advanced GLP-1 page starts at $299/month. The reviewed pages do not consistently assign a complete tirzepatide quote, so request formulation, supply and billing terms.

Can I get a refund from Gide?

Its terms describe final sales and a cutoff once services start or the prescription goes to a pharmacy. The weight-loss page also advertises a money-back promise whose full conditions were not established. Obtain the applicable written policy before paying.

References(6)

  1. Gide Health (2026). Weight-loss program. Gide Health.
  2. Gide Health (2026). Advanced GLP-1 Injection. Gide Health.
  3. Gide Health (2025). Terms of Service. Gide Health.
  4. Gide Health (2026). Tirzepatide — Personalized Billing Plans. Gide Health.
  5. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. Read source
  6. Eli Lilly and Company (2026). Zepbound prescribing information, revised August 2026. U.S. prescribing information. Read source

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.